Catalyst Wire Dossier Catalyst Wire Dossier

VALTYA 1/35

Ethynodiol diacetate and Ethinyl estradiol · Xiromed LLC
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for VALTYA 1/35, covering 2016-07-28 to 2022-04-29. Get the full timeline:

Most recent: FDA Approved: VALTYA 1/35 — Supplemental Application (Xiromed LLC)

See pricing